These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 27544059)

  • 21. The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer.
    Xie B; Dong W; He F; Peng F; Zhang H; Wang W
    Oncology; 2024; 102(9):759-774. PubMed ID: 38262380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients.
    Yam I; Lam DC; Chan K; Chung-Man Ho J; Ip M; Lam WK; Chan TK; Chan V
    J Thorac Oncol; 2012 Jul; 7(7):1131-40. PubMed ID: 22610259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma.
    Zhang N; Li Y; Sun Z; Dong Y; Zhou L; Zhang C; Liu Z; Zhang Q; Li K; Xu F; Zhang L; She B; Ren X; Che N
    J Clin Pathol; 2024 Jul; ():. PubMed ID: 39060112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
    Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
    Zhao J; Lu Y; Ren X; Bian T; Feng J; Sun H; Liu L; She B; Liu Y; Ke H
    BMC Cancer; 2024 Jun; 24(1):687. PubMed ID: 38840077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
    Schmidt B; Beyer J; Dietrich D; Bork I; Liebenberg V; Fleischhacker M
    PLoS One; 2015; 10(2):e0118195. PubMed ID: 25675432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer.
    Zhang J; Yao H; Lai C; Sun X; Yang X; Li S; Guo Y; Luo J; Wen Z; Tang K
    Chin J Cancer Res; 2023 Oct; 35(5):511-525. PubMed ID: 37969955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
    Ji XY; Li H; Chen HH; Lin J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.
    Schneider KU; Dietrich D; Fleischhacker M; Leschber G; Merk J; Schäper F; Stapert HR; Vossenaar ER; Weickmann S; Liebenberg V; Kneip C; Seegebarth A; Erdogan F; Rappold G; Schmidt B
    BMC Cancer; 2011 Mar; 11():102. PubMed ID: 21426551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer.
    Zeng S; Lin C; Huang Y
    Mol Biotechnol; 2023 Jul; 65(7):1187-1197. PubMed ID: 36462101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
    Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
    J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Semi-Nested Real-Time PCR Assay Leveraging Extendable Blocking Probes for Improved
    Phuong NA; Dao TT; Pham PB; Nguyen UD; Nguyen BV; Ho TH
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
    Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Internal Control for Evaluating Bisulfite Conversion in the Analysis of Short Stature Homeobox 2 Methylation in Lung Cancer.
    Lan VTT; Trang VL; Ngan NT; Son HV; Toan NL
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2435-2443. PubMed ID: 31450918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
    Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
    J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-Free
    Jung M; Ellinger J; Gevensleben H; Syring I; Lüders C; de Vos L; Pützer S; Bootz F; Landsberg J; Kristiansen G; Dietrich D
    Clin Chem; 2019 Apr; 65(4):559-568. PubMed ID: 30626634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.
    Schmidt B; Liebenberg V; Dietrich D; Schlegel T; Kneip C; Seegebarth A; Flemming N; Seemann S; Distler J; Lewin J; Tetzner R; Weickmann S; Wille U; Liloglou T; Raji O; Walshaw M; Fleischhacker M; Witt C; Field JK
    BMC Cancer; 2010 Nov; 10():600. PubMed ID: 21047392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.